Lombard Medical, Inc. (EVARF)

Market Cap	28.00
Revenue (ttm)	12.17M
Net Income (ttm)	-31.04M
Shares Out	27.95M
EPS (ttm)	-1.54
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Average Volume	n/a
Open	0.0000
Previous Close	n/a
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0000
Beta	1.90
RSI	n/a
Earnings Date	n/a

About HashiCorp

Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company’s principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of up to 90 degrees. Its products also include Altura endovascular stent graft system for the treatment of standard AAA anatomies; Aorflex del...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 113
• Stock Exchange: OTCMKTS
• Ticker Symbol: EVARF

Financial Performance

In 2016, Lombard Medical's revenue was $12.17 million, a decrease of -19.49% compared to the previous year's $15.11 million. Losses were -$31.04 million, -17.91% less than in 2015.